Ron Cohen - 17 Mar 2022 Form 4 Insider Report for ACORDA THERAPEUTICS INC

Role
President and CEO, Director
Signature
/s/ Ron Cohen
Issuer symbol
N/A
Transactions as of
17 Mar 2022
Net transactions value
-$3,895
Form type
4
Filing time
21 Mar 2022, 16:26:06 UTC
Previous filing
15 Nov 2021
Next filing
20 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACOR Common Stock Sale $3,895 -2,289 -1.7% $1.70 129,601 17 Mar 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These sales are primarily intended to cover the tax liability resulting from the settlement of vested restricted stock units.
F2 The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $1.70 to $1.74 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.